Marker Therapeutics Ownership | Who Owns Marker Therapeutics?


OverviewForecastRevenueFinancialsChart

Marker Therapeutics Ownership Summary


Marker Therapeutics is owned by 20.55% institutional investors, 5.49% insiders, and 73.95% retail investors. Nea management company is the largest institutional shareholder, holding 8.42% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.79% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMarker Therapeutics20.55%5.49%73.95%
SectorHealthcare Stocks 52.57%12.37%35.07%
IndustryBiotech Stocks 52.24%12.07%35.70%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company1.63M8.42%$2.39M
Blue owl capital lp554.25K2.87%$814.75K
Vanguard capital management426.17K2.21%$626.47K
Vanguard group346.07K2.07%$515.65K
Aisling capital management lp325.37K1.68%$478.29K
Renaissance249.42K1.29%$366.65K
Geode capital management139.82K0.72%$205.56K
Advisor group112.65K0.58%$165.59K
Vanguard fiduciary trust87.27K0.45%$128.28K
Lpl financial83.15K0.43%$122.23K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nea management company1.63M0.15%$2.39M
Blue owl capital lp554.25K0.12%$814.75K
Aisling capital management lp325.37K0.10%$478.29K
Invst18.00K0.00%$26.46K
Xtx topco45.36K0.00%$66.67K
Concurrent investment advisors67.96K0.00%$99.91K
Virtu financial11.57K0.00%$17.00K
Ashton thomas private wealth16.40K0.00%$24.11K
Renaissance249.42K0.00%$366.65K
Advisor group112.65K0.00%$165.59K

Top Buyers

HolderShares% AssetsChange
Renaissance249.42K0.00%74.13K
Concurrent investment advisors67.96K0.00%67.96K
Vanguard group346.07K-46.29K
Vanguard capital management426.17K-36.85K
Citadel advisors32.52K-32.52K

Top Sellers

HolderShares% AssetsChange
Hudson bay capital management lp---499.73K
Alyeska investment group---213.02K
Ar asset management---73.70K
Susquehanna group, llp---48.78K
Squarepoint ops---43.30K

New Positions

HolderShares% AssetsChangeValue
Concurrent investment advisors67.96K0.00%67.96K$99.91K
Virtu financial11.57K0.00%11.57K$17.00K
Barclays63.00-63.00$93.00

Sold Out

HolderChange
Citigroup-6.00
Versant capital management-15.00
Western wealth management-368.00
Blackrock funding, inc. /de-992.00
Riggs asset managment-1.20K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202635-2.78%3,970,0101.71%205.03%10-28.57%7-12.50%
Mar 31, 202635-2.78%3,902,873-3.50%254.38%13-31.58%8166.67%
Dec 31, 202526-18.75%1,915,186-44.57%111.86%11-35.29%3-
Sep 30, 202531-3,426,3710.47%242.60%1645.45%3-50.00%
Jun 30, 202530-3.23%3,379,937-17.03%302.26%9-25.00%716.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv298.09K1.79%14.99K
Vanguard Morn Total Stk Mkt Idx Investor298.09K1.79%14.99K
Vanguard MStar Total Stk Mkt Idx Invest298.09K1.79%-
Vanguard US Total Market Shares ETF153.47K1.43%-
Vanguard Institutional Extnd Mkt Idx Tr128.08K0.77%-
Fidelity Extended Market Index72.15K0.43%-15.88K
WEALTHGATE Biotech Aggressive Fund I25.44K0.29%-
Vifag 2002 SICAV30.00K0.23%-
DFA US Small Cap I15.90K0.14%-
Spartan Extended Market Index Pool F21.79K0.13%127.00

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2024ELMS STEVE-Buy$35.47K
Dec 23, 2024New Enterprise Associates 16, L.P.-Buy$1.77M
Mar 16, 2021Eansor Norman David-Buy$249.99K
May 18, 2021Wasserman Frederick Gerald-Buy$24.10K
Mar 16, 2021Walker Paul Edward-Buy$10.00M

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q1--
2024 Q42-
2023 Q2--
2023 Q1--

MRKR Ownership FAQ


Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 20.55%, followed by 5.49% insiders and 73.96% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 52.24%, which Marker Therapeutics falls below.

Who owns the most shares of Marker Therapeutics?

Marker Therapeutics’s largest shareholders are Nea management company (1.63M shares, 8.42%), Blue owl capital lp (554.25K shares, 2.87%), and Vanguard capital management (426.17K shares, 2.21%). Together, they hold 13.49% of Marker Therapeutics’s total shares outstanding.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Nea management company is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 1.63M Marker Therapeutics shares, valued at 2.39M$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.79% of its total shares outstanding invested in 298.09K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools